ArticleDermatology practical & conceptual2014
Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo.
Article in Dermatology practical & conceptual, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05467839 (Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of Efficacy of Microneedling and Topical Methotrexate Versus Microneedling and Topical 5-flourouracil in Treatment of Vitillgo Patients
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review.Frontiers in medicine · 2023Pooled it
- Scoring Systems in Vitiligo-A Narrative Review.Indian dermatology online journal · 2026Article
- Article
- Cullin-3 and Regulatory Biomolecules Profiling in Vitiligo: Integrated Docking, Clinical, and In Silico Insights.Biomolecules · 2025Article
- Association of Serum Vitamin D3 Levels With Vitiligo: A Case-Control Study at a Tertiary Care Center.Cureus · 2025Article
- Evaluation of neutrophil activation marker in patients with vitiligo.Irish journal of medical science · 2024Article
- Evaluation of IL-38, a Newly-introduced Cytokine, in Sera of Vitiligo Patients and Its Relation to Clinical Features.Dermatology practical & conceptual · 2024Article
- Post-Inflammatory Hypopigmentation: Review of the Etiology, Clinical Manifestations, and Treatment Options.Journal of clinical medicine · 2023Review
- Reliability analysis of a novel measurement system for quantifying human skin color.Skin health and disease · 2023Article
- Vitamin D Deficiency in Patients With Vitiligo: A Cross-Sectional Study From Basrah, Iraq.Cureus · 2021Article
- Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study.Archives of dermatological research · 2021Observational
- Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion.Cell death & disease · 2020Article
- Are Patients with Vitiligo More Prone to Myocardial Infarction?: A Case-control Study.The Journal of clinical and aesthetic dermatology · 2019Article
- Clinical profile of vitiligo patients and relationship with immuno-inflammatory markers.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although skin is the largest organ of the body, there are no standardized reproducible methods for assessing severity of many skin diseases. Due to lack of consensus, methods of assessment and inexistence of precise scoring system, there is no application for vitiligo estimation in real practice. In this paper the author describes VETI score as a new treatment evaluation criteria and severity assessment method for vitiligo. This new tool, as does the PASI score in psoriasis, may be able to produce a constant and reproducible number and to help clinical research on vitiligo patients. Additionally it has a potential to be a source of any computed application for researchers working on vitiligo patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.